To elucidate the mechanism by which WYJDTLF modulates lipid metabolism through the JAML/SIRT1 signaling pathway and alleviates diabetic kidney disease (DKD), this study employed a combination of transcriptomic and molecular biology approaches to systematically investigate the therapeutic effects of WYJDTLF. The gene discussed is JAML; the disease is diabetic kidney disease.